MedTrace Logo

A Long-term Safety Study of Infliximab (Remicade)

NCT00261976 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2971

Last updated 2014-03-18

No results posted yet for this study

Summary

This is a study evaluating the long-term safety of infliximab (Remicade)

Conditions

  • Arthritis, Rheumatoid
  • Crohn Disease
  • Psoriasis

Interventions

DRUG

Infliximab (Remicade)

This is an non-interventional study. Participants took the study product as part of their medical routine.

Sponsors & Collaborators

  • Centocor BV

    collaborator INDUSTRY

  • Centocor, Inc.

    lead INDUSTRY

Principal Investigators

  • Centocor, Inc. Clinical Trial · Centocor, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-02-28
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States
  • Argentina
  • Austria
  • Belgium
  • Canada
  • Denmark
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Israel
  • Netherlands
  • Norway
  • Poland
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00261976 on ClinicalTrials.gov